Safety and Efficacy of Once-Daily Administration of Mycophenolate Mofetil in Kidney Transplant Patients—A New Treatment Option for Non-Adherence
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=48457#.VD4U41fHRK0
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=48457#.VD4U41fHRK0
Author(s)
Department of Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine, Suita, Japan.
Department of Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Suita, Japan.
Non-adherence to immunosuppressive therapy is
associated with reduced graft survival. Fifteen long-term follow up
kidney transplant patients with stable post-transplant clinical courses
were enrolled in the study. All patients were prescribed to tacrolimus
prolonged release, mycophenolate mofetil (MMF) and corticosteroid at the
time of enrolment. Twice-daily administration of MMF was then converted
to a single daily dose. As a result, all immunosuppressive agents were
administered simultaneously at one time in the morning. The daily total
doses of the three immunosuppressants were identical during the study
period. No acute rejection or adverse event was observed during the
study period. Blood urea nitrogen and estimated glomerular filtration
rate did not change significantly after conversion to once-daily
administration. The blood tacrolimus trough level and the Mycophenolic
acid (MPA) trough level also did not change significantly after
conversion to once-daily administration. Interestingly, the meanmedian
MPA trough level remained >3 μg/ml even after conversion to
once-daily administration. A sufficient plasma MPA level was maintained
after conversion to once-daily administration, and no acute rejection
was observed during the study period. To our knowledge, this study is
the first to report that the plasma MPA concentration can be maintained
after once-daily administration of MMF in long-term kidney transplant
patients. Once-daily administration of immunosuppressive agents may
improve long-term graft survival because of better treatment adherence
due to the reduced dosing frequency. The safety or efficacy of
conversion to once-daily administration of MMF should be evaluated in a
future randomized controlled large-scale clinical study.
Cite this paper
Ichimaru, N. , Yamanaka, K. , Kato, T. , Kakuta, Y. ,
Abe, T. , Kaimori, J. , Imamura, R. , Nonomura, N. and Takahara, S.
(2014) Safety and Efficacy of Once-Daily Administration of Mycophenolate
Mofetil in Kidney Transplant Patients—A New Treatment Option for
Non-Adherence. Journal of Biomedical Science and Engineering, 7, 788-791. doi: 10.4236/jbise.2014.710077.
| [1] |
De Geest, S., Borgermans, L.,
Gemoets, H., Abraham, I., Vlaminck, H., Evers, G., et al. (1995)
Incidence, Determinants, and Consequences of Subclinical Noncompliance
with Immunosuppressive Therapy in Renal Transplant Recipients.
Transplantation, 59, 340-347. http://dx.doi.org/10.1097/00007890-199502000-00006 |
| [2] |
Butler, J.A., Roderick, P.,
Mullee, M., Mason, J.C. and Peveler, R.C. (2004) Frequency and Impact of
Nonadherence to Immunosuppressants after Renal Transplantation: A
Systematic Review. Transplantation, 77, 769-776. http://dx.doi.org/10.1097/01.TP.0000110408.83054.88 |
| [3] |
Ichimaru, N., Kakuta, Y., Abe,
T., Okumi, M., Imamura, R., Isaka, Y., et al. (2008) Treatment Adherence
in Renal Transplant Recipients: A Questionnaire Survey on
Immunosuppressants. Transplantation Proceedings, 40, 1362-1365. http://dx.doi.org/10.1016/j.transproceed.2008.02.083 |
| [4] |
Obi, Y., Ichimaru, N., Kato, T.,
Kaimori, J.Y., Okumi, M., Yazawa, K., et al. (2013) A Single Daily Dose
Enhances the Adherence to Immunosuppressive Treatment in Kidney
Transplant Recipients: A Cross-Sectional Study. Clinical and
Experimental Nephrology, 17, 310-315. http://dx.doi.org/10.1007/s10157-012-0713-4 |
| [5] |
Bullingham, R., Monroe, S.,
Nicholls, A. and Hale, M. (1996) Pharmacokinetics and Bioavailability of
Mycophenolate Mofetil in Healthy Subjects after Single-Dose Oral and
Intravenous Administration. The Journal of Clinical Pharmacology, 36,
315-324. http://dx.doi.org/10.1002/j.1552-4604.1996.tb04207.x eww141015lx |
评论
发表评论